Control-IQ+ Technology: Intelligent Technology, Optimized Outcomes

By Tandem Cares

Sep 3, 2026

Diabetes Brings a Heavy Mental Load

The mental burden of managing diabetes is multifaceted, with varied impacting daily behaviors, medications, and technology. Helping patients choose an automated insulin delivery (AID) system requires balancing their perceptions and preferences with the wide range of system features, algorithms, and settings, all aimed at achieving the best possible outcomes.

Control-IQ+: The Only System with Predictive AutoBolus*

Continuous Automation + AutoBolus reduces user burden and improves outcomes.

  • Control-IQ+ uses predictive CGM values; looking ahead 30 minutes every 5-minutes

  • Basal delivery responds to gradual changes in predicted glucose

  • AutoBolus proactively delivers a bolus to help prevent and treat hyperglycemia (>180 mg/dL)*

  • Predictive values enable optimized response to both rapid and gradual changes in glucose

Control IQ+ with predictive Autobolus

More Time in Automation Results in Higher Time in Range

Unlike other systems, Control-IQ+ does NOT kick patients out of automation due to:

  • Persistent highs or lows

  • Missed calibrations

  • Insulin delivery methods

Control-IQ+ outperforms Omnipod 5 for inconsistent bolusers1

  • ~4 hours more / day spent in automation compared to Omnipod 51

  • +8% greater time in range compared to Omnipod 51

Tandem prioritizes choice to fit patient needs

Control-IQ+ powers both Tandem form factors — the t:slim X2 pump and the Tandem Mobi system.

The all-in-one t:slim X2 insulin pump features a sleek, color touchscreen and holds up to 300 units of insulin. Patients have the option to bolus from a compatible smartphone using the Tandem t:slim Mobile app. The t:slim X2 pump is compatible with Dexcom G7 CGM Systems and the Abbott FreeStyle Libre 3 Plus Sensor.

Tandem Mobi offers wearability like never before with three different wear options – on-body with the adhesive sleeve (sold separately), clipped to clothing with the pump case, or slipped into a pocket. Tandem Mobi holds 200 units of insulin and is fully controlled by a compatible iOS or Android smartphone. Tandem Mobi is compatible with the Dexcom G7 CGM System.

Both pumps are compatible with a variety of infusion sets offering different cannula lengths, materials, and angles and a variety of tubing lengths – including 5” tubing allowing the Tandem Mobi to be worn on body.

Explore the Simplified Prescribing Journey Today:
https://www.tandemdiabetes.com/healthcare-professionals/cost-and-coverage

*If glucose values are predicted to be above 180 mg/dL, Control-IQ+ technology calculates an AutoBolus using the Personal Profile settings and a target of 110 mg/dL and delivers 60% of that value.

Reference:

  1. Chatty P, Gera S, Rearson A, et al. Effect of low bolus frequency on automated insulin delivery system performance in youth with type 1 diabetes. Diabetes Care. 2026;49(2):303-307.

Important Safety Information:

RX ONLY.

Indicated for patients with type 1 diabetes, 2 years and older and for patients with type 2 diabetes, 18 years and older. BOXED WARNING: Control-IQ+ technology should not be used in anyone under the age of 2 years old with type 1 diabetes or under the age of 18 years old with type 2 diabetes. It should also not be used in patients who require less than a total daily insulin dose of 5 units of insulin per day or who weigh less than 20 pounds, as those are the required minimum values needed for Control-IQ+ to operate safely. Safety info: tandemdiabetes.com/safetyinfo.

For Tandem t:slim mobile app Important Safety Information, visit: tandemdiabetes.com/safetyinfo.

© 2026 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Tandem logos, Control-IQ+, t:slim, t:slim X2, and Tandem Mobi are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. Dexcom, Dexcom G7, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott and used with permission. iOS is a trademark or registered trademark of Cisco in the U.S. and other countries and is used under license. Android is a trademark of Google LLC. All third-party marks are the property of their respective owners.